FERTIN PHARMA

Live / Applied — Second extension granted (statement of use) (as of 25 Nov 2025)

What this means for you

Not registered yet, but its 21 Dec 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98326058
Mark type
Design + words
Filed
21 Dec 2023
Published for opposition
15 Oct 2024
Attorney of record
Tamar Niv Bessinger

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, smoking cessation preparations, analgesic preparations, sleep aid- preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical preparations, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders in chewable form, in gum form, in lozenge form, and in pouch powder form; aerosolized and inhaled therapeutics and pharmaceuticals, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti- pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical preparations for inhalation, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; drug delivery agents in the form of fast liquefiable tablets, compressed gum, extruded gum, lozenges, pouch powder, dissolvable films, coatings for tablets, and transdermal patches that facilitate the delivery of pharmaceutical preparations, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; vitamins and dietary supplements; dietetic foodstuffs adapted for medical purposes; nicotine gum for use as an aid to stop smoking; medicated chewing gum as a drug delivery agent to facilitate the delivery of pharmaceutical preparations; dietetic preparations for medical use; herbal extracts for medical purposes; herbal teas for medicinal purposes
  • Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals and nutraceuticals; consultancy regarding the custom manufacture of pharmaceuticals and nutraceuticals; custom manufacture of pharmaceuticals, namely, formulation of pharmaceutical preparations for treatment of a wide variety of conditions in chewable form, in gum form, in lozenge form, and in pouch powder form; custom manufacture of pharmaceuticals, namely, formulation of inhaled therapeutics; custom manufacture of pharmaceuticals, namely, formulation of pharmaceuticals and well-being products for oral and intra-oral delivery systems; research, and development of pharmaceuticals and well-being products for oral and intra-oral delivery systems; custom manufacture of pharmaceuticals, namely, formulation of pharmaceuticals for smoking cessation; provision of advice, information and consultancy in relation to the aforesaid services
  • Class 042 — Scientific and technological services: Scientific, medical and technological services and research and design relating thereto namely, research and development of technology in the field of smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; industrial analysis and industrial research services in the field of pharmaceutical research and development services; research, and development of pharmaceutical preparations for treatment of a wide variety of conditions in chewable form, in gum form, in lozenge form, and in pouch powder form; research and development of inhaled therapeutics; research, and development of pharmaceuticals and well-being products for oral and intra-oral delivery systems; research and development of pharmaceuticals for smoking cessation; provision of advice, information and consultancy in relation to the aforesaid service

Owner

Prosecution history

  • 26 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 25 Nov 2025 — SOU EXTENSION 2 GRANTED
  • 25 Nov 2025 — SOU EXTENSION 2 FILED
  • 25 Nov 2025 — SOU TEAS EXTENSION RECEIVED
  • 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 14 Jan 2025 — SOU EXTENSION 1 GRANTED
  • 13 Jan 2025 — SOU EXTENSION 1 FILED
  • 13 Jan 2025 — SOU TEAS EXTENSION RECEIVED
  • 26 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 15 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 15 Oct 2024 — PUBLISHED FOR OPPOSITION
  • 25 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 05 Sept 2024 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
  • 04 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 04 Sept 2024 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

View this trademark record on Marksy